Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MDA-MB-231 | GSK2334470 | 0.001 | 0.9785 | -0.00786 |
| MDA-MB-231 | GSK2334470 | 0.001 | 0.9898 | -0.00194 |
| MDA-MB-231 | GSK2334470 | 0.003162278 | 0.8739 | -0.00229 |
| MDA-MB-231 | GSK2334470 | 0.003162278 | 0.9235 | -0.00202 |
| MDA-MB-231 | GSK2334470 | 0.003162278 | 0.9948 | -0.00185 |
| MDA-MB-231 | GSK2334470 | 0.01 | 0.8338 | 0.00167 |
| MDA-MB-231 | GSK2334470 | 0.01 | 0.7222 | 0.00499 |
| MDA-MB-231 | GSK2334470 | 0.01 | 0.9452 | 0.00072 |
| MDA-MB-231 | GSK2334470 | 0.031622777 | 0.7860 | 0.00268 |
| MDA-MB-231 | GSK2334470 | 0.031622777 | 0.9413 | 0.00766 |
| MDA-MB-231 | GSK2334470 | 0.031622777 | 0.9089 | -0.00420 |
| MDA-MB-231 | GSK2334470 | 0.1 | 0.9260 | 0.00276 |
| MDA-MB-231 | GSK2334470 | 0.1 | 0.9095 | -0.00380 |
| MDA-MB-231 | GSK2334470 | 0.1 | 0.9164 | 0.00016 |
| MDA-MB-231 | GSK2334470 | 0.316227766 | 0.8570 | -0.00326 |
| MDA-MB-231 | GSK2334470 | 0.316227766 | 0.7866 | 0.00313 |
| MDA-MB-231 | GSK2334470 | 0.316227766 | 0.8303 | -0.00048 |
| MDA-MB-231 | GSK2334470 | 1.0 | 0.6745 | 0.00598 |
| MDA-MB-231 | GSK2334470 | 1.0 | 0.8035 | 0.00613 |
| MDA-MB-231 | GSK2334470 | 1.0 | 0.8137 | 0.00696 |
| MDA-MB-231 | GSK2334470 | 3.16227766 | 0.7967 | 0.00286 |
| MDA-MB-231 | GSK2334470 | 3.16227766 | 0.8001 | -0.00236 |
| MDA-MB-231 | GSK2334470 | 3.16227766 | 0.7747 | 0.01339 |
| MDA-MB-231 | GSK2334470 | 10.0 | 0.6188 | 0.00382 |
| MDA-MB-231 | GSK2334470 | 10.0 | 0.5782 | 0.00482 |